Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fingolimod vs Standard DMT in Relapsing MS (EPOC)
NCT01216072Phase 4Completed
- Sponsor
- Novartis
- Start
- Aug 2010
- Primary completion
- Aug 2012
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 4 trial of fingolimod in multiple sclerosis (MS), sponsored by Novartis. Started Aug 2010; status: completed.
02
Drugs
fingolimod
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT01216072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01216072.